Instinct Bio Technical Company Holdings Inc.

US$0.19As of Sun 8 Nov 2026, 12:00 UTC

NASDAQ:BIOTConsumer Def

Country USA

PE (Fwd) —

TSR 10Y CAGR —

Div yield —

ROE 3.21%

Household & Personal Products

Beta (5Y) —

PE TTM —

TSR TTM —

Mkt cap US$5.471M

ROIC (2.93%)

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

$0.207

8.69%

(55.66%)

Price above Reference Value

TTM

FYE 30 Nov USD

FY2023

FY2024

FY2025E

FY2026E

Trend

10Y

Peers

2.761

Revenue$M

—

3.433

2.761

2.476

2.344

(19.58%)

—

(19.58)

Revenue growth%

—

(19.58)

(10.32)

(5.30)

(19.58)

—

72.40

Gross margin%

—

86.72

72.40

65.24

61.67

79.56

—

(2.46)

Operating margin%

—

11.62

(2.46)

(9.50)

(13.02)

4.58

—

2.70

Net margin%

—

15.87

2.70

(3.88)

(7.17)

9.29

—

P/E ratio (avg)x

—

EV/EBITx

—

FCF yield (avg)%

—

20.75

25.10

—

20.39

FCF margin%

—

(30.53)

20.39

45.85

58.58

(5.07)

—

7.540

FCF / Net incomex

—

(1.924)

7.540

—

2.808

—

(2.93)

ROIC%

—

15.47

(2.93)

(16.31)

(546.13)

6.27

—

3.21

Return on equity%

—

23.61

3.21

(4.20)

(7.80)

13.41

—

2.40

Return on assets%

—

15.95

2.40

(3.19)

(5.92)

9.18

—

EPS$

—

(0.01)

—

EPS growth%

—

(75.05)

—

Bookvalue per sh$

—

0.08

0.07

—

FCF per share$

—

0.04

0.05

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

28.79

Shares (diluted)M

—

◌28.79

—

Buyback yield%

—

◌—

—

0.100

D/E ratiox

—

0.221

0.100

0.104

0.113

0.161

—

5.192

Enterprise value$M

—

4.057

2.683

—

LT debt$M

—

Peers (US$5.038M)

Cap (US$)

Liberta Co.,Ltd.

27.14M

—

Nippon Shikizai, Inc.

13.62M

8.121x

Asahi Eito Holdings…

10.28M

—

Skin Elements Limited

4.796M

—

Capital

TTM

10Y

Leveragex

(1.652)

(0.607)

EBIT/Intx

(19.09)

14.01

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

69.42

—

Short interest%

1.23

SBC / revenue%

—

Record

10Y

Profitable years

—

Revenue growth years

—

EPS growth years

—

Dividend streakyrs

—

Op margin range%

—

$1 testx

—

Incr. ROIC%

—

Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.

Growth vs revenue

Latest

Trend

1Y CAGR

Rel growth

Revenue

$2.761M

(19.58%)

1.00×

Cost of revenue

$0.762M

67.07%

2.08×

Operating expenses

$2.067M

(19.83%)

1.00×

Asset mix

Trend

Other

82.25%

Cash and investments

16.50%

Goodwill & intangibles

1.25%

Reinvestment returns

No breakdown available